Sigma公案例分析.docVIP

Contents Part 1 History and Major Activities …………………………………………2 Part 2 Industry Characteristics Rivalry Among Existing Firms……………………………………3 Threat of New Entrants……………………………………………3 Threat of Substitute Products ……………………………………4 Bargaining Power of Buyers………………………………………4 Bargaining Power of Suppliers……………………………………5 Part 3 Competitive Strategy……………………………………………………6 Reference ………………………………………………………………7 Part 1 History and Major Activities Sigma is a large company in the pharmaceutical industry and it has a long history. In 1912, two Melbourne pharmacists established it. After a prolonged endeavour, now Sigma plays an important role in this industry. Sigma began its manufacturing activities in 1942. After fifty-four years, it acquired QDL. And in the next year, Sigma Company Ltd was listed on the Exempt Stock Exchange. Guardian pharmacy group and Amcal pharmacy group were acquired successfully in the following year. In 1999, Smith Kline Beechams Dandenong manufacturing facility was acquired. And in the same year, Sigma incorporated Arrow Pharmaceuticals, which was listed on the ASX in 2002. In 2003, Sigma Company acquired Herron Pharmaceuticals and Chemists Own. And in 2005, Sigma Company Ltd and Arrow Pharmaceuticals Ltd merged and are renamed Sigma Pharmaceuticals Ltd. In 2008, Sigma Pharmaceuticals acquires Orphan Australia. Recently, Sigma divested its Pharmaceutical Division to Aspen Pharmacare Holdings. Now, Sigma engaged in the manufacturing, development and distribution of own branded and contract OTC (over the counter), prescription and generic pharmaceutical products for the Australian and overseas markets.. Sigma is also the owner of some of Australias best known pharmacy brands in Amcal, Guardian and Amcal Max. Sigma Healthcare Division was created to align Sigma wholesale and retail services to provide even greater value to primary customer, Community Pharmacists. The Sigma Healthcare Division provides all pharmacist customers with an extensive range